Scientific Opinion on the re-evaluation of ascorbic acid (E 300), sodium ascorbate (E 301) and calcium ascorbate (E 302) as food additives

EFSA Journal

Volumn 13, Issue 5, 2015, Pages

[No Author Info available]

Author keywords

ascorbic acid (E 300); calcium ascorbate (E 302); Food additives; sodium ascorbate (E 301); vitamin C

Indexed keywords

EID: 85078101347     PISSN: None     EISSN: 18314732     Source Type: Journal    
DOI: 10.2903/j.efsa.2015.4087     Document Type: Article

References (189)

1. Alleva FR, Alleva JJ and Balazs T, 1976. Effect of large daily doses of ascorbic-acid on pregnancy in guinea pigs, rats, and hamsters. Toxicology and Applied Pharmacology, 35, 393–395.
2. Alvi S, Khan KM, Sheikh MA and Shahid M, 2003. Effect of peeling and cooking on nutrients in vegetables. Pakistan Journal of Nutrition, 2, 189–191.
3. Amabile-Cuevas CH, 1988. Loss of penicillinase plasmids of Staphylococcus aureus after treatment with L-ascorbic acid. Mutation Research, 207, 107–109.
4. Amacher DE and Paillet SC, 1981. Ascorbate is not detectably mutagenic in the L5178Y TK±cell mutation assay. Cancer Letters, 14, 151–158.
5. Ancos B, Gonzalez EM and Cano MP, 2000. Ellagic acid, vitamin C, and total phenolic contents and radical scavenging capacity affected by freezing and frozen storage in raspberry fruit. Journal of Agricultural and Food Chemistry, 48, 4565–4570.
6. Anderson D, Basaran N, Blowers SD and Edwards AJ, 1995. The effect of antioxidants on bleomycin treatment in in vitro and in vivo genotoxicity assays. Mutation Research, 329, 37–47.
7. Arnold, DL et al., 1977. Long term toxicity study with orthotoluene-sulfonamide and saccharin.Toxicology and Applied Pharmacology, 41, 164, abstract No 78 (as referred to by JECFA, 1993).
8. Arnold DL, Moodie CA, Grice HC, Charbonneau SM, Stavric B, Colllins BT, McGuyire PF, Zawidska ZZ and Munro IC, 1980. Long-term toxicity of orthotoluene- sulfonamide and sodium saccharin in the rat. Toxicology and Applied Pharmacology, 52, 113–152.
9. Auer BL, Auer D and Rodgers AL, 1998. The effect of ascorbic acid ingestion on the biochemical and physicochemical risk factors associated with calcium oxalate kidney stone formation. Clinical Chemistry and Laboratory Medicine, 36, 143–147.
10. Bächtold, 1972. Akute Toxizitätsversuche von vitamin C, dessen Vorstufen und einigen möglichen Zersetzungsprodukten. Interne mitteilung No 4155. Unpublished study report submitted by DSM, July 2010.
11. Bächtold, 1973. Prüfung im 5-tage-toxizitätsversuch an mäusen und ratten. Calcium ascorbat, ascorbinsäure, Natrium ascorbat. Interne mitteilung No 4670. Unpublished study report submitted by DSM, July 2010.
12. Baker EM, Hodges RE, Hood J, Sauberli HE and March SC, 1969. Metabolism of ascorbic-1-14C acid in experimental human scurvy. American Journal of Clinical Nutrition, 22, 549–558.
13. Barness LA, 1975. Safety considerations with high ascorbic-acid dosage. Annals of the New York Academy of Sciences, 258, 523–528.
14. Barraquio V, 2014. Which milk is fresh? International Journal of Dairy Science and Processing, 1, 201.
15. BfR (Bundesinstitut für Risikobewertung [Federal Institute for Risk Assessment]), 2005. Indications of the possible formation of benzene from benzoic acid in foods. BfR Expert Opinion No 013/2006, 1 December 2005. Available online: http://www.bfr.bund.de/cm/349/indications_of_the_possible_formation_of_benzene_from_benzoic_acid_in_foods.pdf.
16. BfR (Bundesinstitut für Risikobewertung [Federal Institute for Risk Assessment]), 2013. Fragen und Antworten zu Benzol in Erfrischungsgetränken und Karottensäften. Aktualisierte FAQ des BfR vom 16. December 2013. Available online: http://www.bfr.bund.de/cm/343/fragen-und-antworten-zu-benzol-in-erfrischungsgetraenken-und-karottensaeften.pdf.
17. Blanchard J, Tozer TN and Rowland M, 1997. Pharmacokinetic perspectives on megadoses of ascorbic acid. American Journal of Clinical Nutrition, 66, 1165–1171.
18. Blasiak J, Trzeciak A, Dziki A, Ulaňka J and Pander B, 2000. Synergistic effect of vitamin C on DNA damage induced by cadmium. General Physiology and Biophysics, 19, 373–379.
19. Bode AM, Cunningham L and Rose RC, 1990. Spontaneous decay of oxidised ascorbic acid (dehydro-L-ascorbic acid) evaluated by high-pressure liquid chromatography. Clinical Chemistry, 36, 1807–1809.
20. Bognár A and Daood HG, 2000. Simple in-line postcolumn oxidation and derivatization for the simultaneous analysis of ascorbic and dehydroascorbic acids in Foods. Journal of Chromatographic Science, 38, 162–168.
21. Bosch V, Cilla A, García-Llatas G, Gilabert V, Boix R and Alegría A, 2013. Kinetics of ascorbic acid degradation in fruit-based infant foods during storage. Journal of Food Engineering, 116, 298–303.
22. Briggs M, 1976. Vitamin-C-induced hyperoxaluria. Lancet, 1, 154–154.
23. Bruce R and Heddle JA, 1979. The mutagenic activity of 61 agents as determined by the micronucleus, Salmonella, and sperm abnormality assays. Canadian Journal of Genetics and Cytology, 21, 319–334.
24. Burdurlu HS, Koca N and Karadeniz F, 2006. Degradation of vitamin C in citrus juice concentrates during storage. Journal of Food Engineering, 74, 211–216.
25. Cameron E and Campbell A, 1974. Orthomolecular treatment of cancer.2. Clinical trial of high-dose ascorbic-acid supplements in advanced human cancer. Chemico-Biological Interactions, 9, 285–315.
26. Carr A and Frei B, 1999. Does vitamin C act as a pro-oxidant under physiological conditions? FASEB Journal, 13, 1007–1024 (as referred to by EFSA NDA Panel, 2013).
27. Chang P and Ku K, 1993. Studies on benzene formation in beverages. Journal of Food and Drug Analysis, 1, 385–393.
28. CIR (Cosmetic Ingredient Review), 2005. Final report of the safety assessment of L-ascorbic acid, calcium ascorbate, magnesium ascorbate, magnesium ascorbyl phosphate, sodium ascorbate, and sodium ascorbyl phosphate as used in cosmetics. Report prepared by Elmore AR. International Journal of Toxicology, 24, 51–111.
29. Central Institute for Food and Nutrition Research (CIVO-TNO), 2003. In vivo gene mutation by use of lambda Z-transgenic mice with furfural. Steenwinkel M-JST. Project no 01044074. 1 May 2003. Unpublished report (as referred to by EFSA CEF Panel, 2011).
30. Cohen SM, Ellwein LB, Okamura T, Masui T, Johansson SL, Smith RA, Wehner JM, Khachab M, Chappel CI, Schoenig GP, Emerson JL and Garland EM, 1991. Comparative bladder-tumour promoting activity of sodium saccharin, sodium ascorbate, related acids, and calcium salts in rats. Cancer Research, 51, 1766–1777.
31. Cohen SM, Anderson TA, De Oliveira LM and Arnold LL, 1998. Tumorigenicity of sodium ascorbate in male rats. Cancer Research, 58, 2557–2561.
32. Curhan GC, Willett WC, Rimm EB and Stampfer MJ, 1996. A prospective study of the intake of vitamins C and B6, and the risk of kidney stones in men. Journal of Urology, 155, 1847–1851.
33. Curhan GC, Willett WC, Speizer FE and Stampfer MJ, 1999. Intake of vitamins B6 and C and the risk of kidney stones in women. Journal of the American Society of Nephrology, 10, 840–845.
34. Duarte TL, Almeida GM and Jones GDD, 2007. Investigation of the role of extracellular H2O2 and transition metal ions in the genotoxic action of ascorbic acid in cell culture models. Toxicology Letters, 170, 57–65.
35. Duthie SJ, Ma AG, Ross MA and Collins AR, 1996. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Research, 56, 1291–1295.
36. EC (European Commission), 2007a. Summary record of the Standing Committee on the Food Chain and Animal Health. Held in Brussels on 20 July 2007. SANCO – D1(2007)D/411718. Available online: http://ec.europa.eu/food/committees/regulatory/scfcah/toxic/summary20072007_en.pdf.
37. EC (European Commission), 2007b. Summary record of the Standing Committee on the Food Chain and Animal Health. Held in Brussels on 14 December 2007. SANCO – D1(2007)D/412774. Available online: http://ec.europa.eu/food/committees/regulatory/scfcah/toxic/summary14122007_en.pdf.
38. Edwards A, 1999. Draft report. An in vivo unscheduled DNA synthesis assay in the mouse with furfural. Report no 3389/1/1/99. BIBRA International, Carshalton (as referred to by EFSA CEF Panel, 2011).
39. EFSA (European Food Safety Authority), 2004. Scientific opinion of the Panel on Dietetic Products, Nutrition and Allergies (NDA) on a request from the Commission related to the Tolerable Upper Intake Level of Vitamin C (L-Ascorbic acid, its calcium, potassium and sodium salts and L-ascorbyl-6-palmitate). The EFSA Journal 2004, 59, 1–21.
40. EFSA (European Food Safety Authority), 2005. Opinion of the Scientific Panel on Dietetic products, nutrition and allergies (NDA) related to the Tolerable Upper Intake Level of Sodium. The EFSA Journal 2005, 209, 1–26.
41. EFSA (European Food Safety Authority), 2007. Scientific opinion of the Scientific Committee related to uncertainties in dietary exposure assessment. The EFSA Journal 2007, 438, 1–54.
42. EFSA (European Food Safety Authority), 2006. Scientific opinion of the Panel on food additives, flavourings, processing aids and materials in contact with food (AFC) related to calcium ascorbate with a content of threonate for use as a source of vitamin C in food supplements. The EFSA Journal 2006, 491, 1–10.
43. EFSA (European Food Safety Authority), 2008. Scientific opinion of the Panel on Food Additives and Nutrient Sources added to food (ANS) on calcium L-threonate for use as a source of calcium in food supplements. The EFSA Journal 2008, 866, 1–20.
44. EFSA (European Food Safety Authority), 2009. Scientific opinion of the Panel on Food Additives and Nutrient Sources added to food (ANS) on calcium ascorbate, magnesium ascorbate and zinc ascorbate added for nutritional purposes in food supplements. The EFSA Journal 2009, 994, 1–22.
45. EFSA (European Food Safety Authority), 2010. Management of left-censored data in dietary exposure assessment of chemical substances. EFSA Journal 2010;8(3):1557, 96 pp. doi:10.2903/j.efsa.2010.1557.
46. EFSA (European Food Safety Authority), 2011a. Statement of EFSA on the safety of calcium L-ascorbate with a content of threonate produced by a new manufacturing process as a source of vitamin C in food supplements. EFSA Journal 2011;9(9):2395, 17pp. doi:10.2903/j.efsa.2010.2395.
47. EFSA (European Food Safety Authority), 2011b. Use of the EFSA Comprehensive European Food Consumption Database in Exposure Assessment. EFSA Journal 2011;9(3):2097, 34 pp. doi:10.2903/j.efsa.2011.2097.
48. EFSA (European Food Safety Authority), 2011c. Evaluation of the FoodEx, the food classification system applied to the development of the EFSA Comprehensive European Food Consumption Database. EFSA Journal 2011;9(3):1970, 27 pp. doi:10.2903/j.efsa.2011.1970.
49. EFSA Panel on Food Additives and Nutrient Sources (ANS), 2010. Scientific Opinion on the use of sodium ascorbate as a food additive in vitamin D preparations intended to be used in formulae and weaning food for infants and young children. EFSA Journal 2010;8(12):1942, 13 pp. doi:10.2903/j.efsa.2010.1942.
50. EFSA Panel on Food Additives and Nutrient Sources (ANS), 2011a. Scientific Opinion on re-evaluation of calcium carbonate (E 170) as a food additive. EFSA Journal 2011;9(7):2318, 73 pp. doi:10.2903/j.efsa.2011.2318.
51. EFSA Panel on Food Additives and Nutrient Sources (ANS), 2011b. Scientific Opinion on the re-evaluation of caramel colours (E 150 a,b,c,d) as food additives. EFSA Journal 2011;9(3):2004, 103 pp. doi:10.2903/j.efsa.2011.2004.
52. EFSA ANS Panel (EFSA Panel on Food Additives and Nutrient Sources Added to Food), 2014. Statement on a conceptual framework for the risk assessment of certain food additives re-evaluated under Commission Regulation (EU) No 257/2010. EFSA Journal 2014;12(6):3697, 11 pp. doi:10.2903/j.efsa.2014.3697.
53. EFSA Panel on Food Contact Materials, Enzymes, Flavouring and Processing Aids (CEF), 2010. Scientific opinion on Flavouring Group Evaluation 13 Revision 1 (FGE.13.Rev1): Furfuryl and furan derivatives with and without additional side-chain substituents and heteroatoms from chemical group 14. The EFSA Journal 2010;8(4):1403, 112 pp. doi:10.2903/j.efsa.2010.1403.
54. EFSA Panel on Food Contact Materials, Enzymes, Flavouring and Processing Aids (CEF), 2011. Scientific opinion on Flavouring Group Evaluation 218, Revision 1 (FGE.218.Rev1): alpha, beta-Unsaturated aldehydes and precursors from subgroup 4.2 of FGE.19: Furfural derivatives. The EFSA Journal 2011;9(3):1840, 112 pp. doi:10.2903/j.efsa.2011.1840.
55. EFSA Panel on Contaminants in Food Chain (CONTAM), 2009. Scientific Opinion on arsenic in food. The EFSA Journal 2009;7(10):1351, 199 pp. doi:10.2903/j.efsa.2009.1351.
56. EFSA Panel on Contaminants in Food Chain (CONTAM), 2010. Scientific Opinion on lead in food. The EFSA Journal 2010;8(4):1570, 151 pp. doi:10.2903/j.efsa.2010.1570.
57. EFSA Panel on Contaminants in Food Chain (CONTAM), 2012. Scientific Opinion on the risk for public health related to the presence of mercury and methylmercury in food. The EFSA Journal 2012;10(12):2985, 241 pp. doi:10.2903/j.efsa.2012.2985.
58. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), 2013a. Scientific Opinion on the safety and efficacy of vitamin C (ascorbic acid and sodium calcium ascorbyl phosphate) as a feed additive for all animal species based on a dossier submitted by VITAC EEIG. EFSA Journal 2013;11(2):3103, 25 pp. doi:10.2903/j.efsa.2013.3103.
59. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), 2013b. Scientific Opinion on the safety and efficacy of vitamin C (ascorbic acid, sodium ascorbate, calcium ascorbate, ascorbyl palmitate, sodium calcium ascorbyl phosphate and sodium ascorbyl phosphate) as a feed additive for all animal species based on a dossier submitted by DSM Nutritional Products Ltd. EFSA Journal 2013;11(2):3104, 36 pp. doi:10.2903/j.efsa.2013.3104.
60. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2009. Scientific opinion on the substantiation of health claims related to vitamin C and protection of DNA, proteins and lipids from oxidative damage (ID 129, 138, 143, 148), antioxidant function of lutein (ID 146), maintenance of vision (ID 141, 142), collagen formation (ID 130, 131, 136, 137, 149), function of the nervous system (ID 133), function of the immune system (ID 134), function of the immune system during and after extreme physical exercise (ID 144), non-haem iron absorption (ID 132, 147), energy-yielding metabolism (ID 135), and relief in case of irritation in the upper respiratory tract (ID 1714, 1715) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2009;7(9):1226, 28 pp. doi:10.2903/j.efsa.2009.1226.
61. E EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2010a. Scientific Opinion on the substantiation of a health claim related to a combination of blackcurrant seed oil, fish oil, lycopene, vitamin C, and vitamin E and helps to improve dry skin conditions pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal 2010;8(5):1608, 13 pp. doi:10.2903/j.efsa.2010.1608.
62. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), 2010b. Scientific Opinion on the substantiation of health claims related to vitamin C and reduction of tiredness and fatigue (ID 139, 2622), contribution to normal psychological functions (ID 140), regeneration of the reduced form of vitamin E (ID 202), contribution to normal energy-yielding metabolism (ID 2334, 3196), maintenance of the normal function of the immune system (ID 4321) and protection of DNA, proteins and lipids from oxidative damage (ID 3331) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal 2010;8(10):1815, 20 pp. doi:10.2903/j.efsa.2010.1815.
63. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2013. Scientific Opinion on dietary reference values for vitamin C. EFSA Journal 2013;11(11):3418, 68 pp. doi:10.2903/j.efsa.2013.3418.
64. EFSA Scientific Committee, 2012. Guidance on selected default values to be used by the EFSA Scientific Committee, Scientific Panels and Units in the absence of actual measured data. EFSA Journal 2012;10(3):2579, 32 pp. doi:10.2903/j.efsa.2012.2579.
65. European Pharmacopoeia, 2014. 8th edition, Band 2. pp. 2157–2159.
66. Elez-Martínez P and Martín-Belloso O, 2007. Effects of high intensity pulsed electric field processing conditions on vitamin C and antioxidant capacity of orange juice and gazpacho, a cold vegetable soup. Food Chemistry, 102, 201–209.
67. EVM (Expert Group on Vitamins and Minerals), 2002. Expert Group on vitamins and minerals: revised review of vitamin C. EVM/99/21.REVISEDAUGUST2002. Available online: http://www.food.gov.uk/multimedia/pdfs/vitaminc.pdf.
68. EVM (Expert Group on Vitamins and Minerals), 2003. Safe upper levels for vitamins and minerals. Available online: www.food.gov.uk/multimedia/pdfs/vitmin2003.pdf.
69. FAO/WHO (Food and Agriculture Organization of the United Nations/World Health Organization), 2004. Vitamin and Mineral Requirements in Human Nutrition. Second Edition. Chapter 7, Vitamin C. 130-139. Available online: http://whqlibdoc.who.int/publications/2004/9241546123.pdf.
70. FASEB (Federation of American Societies for Experimental Biology), 1979. Evaluation of the health aspects of ascorbic acid, sodium ascorbate, calcium ascorbate, erythorbic acid, sodium erythorbate, and ascorbyl palmitate as food ingredients. Report prepared for FDA by the Select Committee of GRAS Substances (SCOGS) under contract No FDA 223-75-2004. SCOGS-59.
71. Fenton HJH, 1894. LXXIII – Oxidation of tartaric acid in presence of iron. Journal of the Chemical Society Transactions, 65, 899–910.
72. FNB (Food and Nutrition Board), 2000. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. National Academy of Sciences. Institute of Medicine. Food and Nutrition Board. Available online: http://fnic.nal.usda.gov/nal_display/index.php?info_center=4&tax_level=4&tax_subject=256&topic_id=1342&level1343_id=5141&level1344_id=10591.
73. Fontannaz P, Kilinc T and Heudi O, 2006. HPLC-UV determination of total vitamin C in a wide range of fortified food products. Food Chemistry, 94, 626–231.
74. Frenzilli G, Bosco E and Barale R, 2000. Validation of single cell gel assay in human leucocytes with 18 reference compounds. Mutation Research, 468, 93–108.
75. Frias J, Penas E, Ullat M and Vidal-Valverde C, 2010. Influence of drying by convective air dryer or power ultrasoind on the vitamin C and beta-carotene content of carrots. Journal of Agricultural and Food Chemistry, 58, 10539–10544.
76. Frohberg H, Gleich J and Kieser H, 1973. Reproduktionstoxikologische studien mit ascorbinsaure an mausen and ratten [Reproduction-toxicologic studies on ascorbic-acid in mice and rats]. Arzneimittel-Forschung [Drug Research], 23, 1081–1082.
77. Galloway SM and Painter RB, 1979. Vitamin C is positive in the DNA synthesis inhibition and sister-chromatic exchange test. Mutation Research, 60, 321–327.
78. Gandini S, Merzenich H, Robertson C and Boyle P, 2000. Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. European Journal of Cancer, 36, 636–646.
79. Gardner LK and Lawrence GD, 1993. Benzene production from decarboxylation of benzoic acid in the presence of ascorbic acid and a transition-metal catalyst. Journal of Agricultural and Food Chemistry, 41, 693–695.
80. Golaszewska B and Zalewski S, 2001. Optimization of potato quality in culinary process. Journal of Food and Nutrition Sciences, 10, 59–63.
81. Gonçalves EM, Cruz RMS, Abreu M, Branda, TRS and Silva CLM, 2009. Biochemical and colour changes of watercress (Nasturtium officinale R. Br.) during freezing and frozen storage. Journal of Food Engineering, 93, 32–39.
82. Gonzalez MJ, Riordan HD and Miranda-Massari JR, 2002. Vitamin C and oxidative DNA damage revisited. Journal of Orthomolecular Medicine, 17, 225–228.
83. Greggi Antunes LM and Takahashi CS, 1999. Protection and induction of chromosomal damage by vitamin C in human lymphocyte cultures. Teratogenesis, Carcinogenesis and Mutagenesis, 19, 53–59.
84. Gregory JF, 1996. Vitamins. In:Food chemistry, 3rd Edition. Eds O R Fennema; Marcel Dekker Inc; NewYork, USA, pp. 559–568.
85. Gulati DK, Witt K, Anderson B, Zeiger E and Shelby M, 1989. Chromosome aberration and sister chromatid exchange test in Chinese hamster ovarycells in vitro III: results of 27 chemicals. Environmental and Molecular Mutagenesis, 13, 133–193.
86. Halliwell B and Gutteridge JMC, 1989. Free radicals in biology and medicine. Clarendon Press, Oxford, UK, 543 pp (as referred to EFSA NDA Panel, 2013).
87. Hornig D, 1973. Einfluss hoher Dosen Ascorbinsäure auf ausgewählte Parameter beim Meerschweinchen. Unpublished study report.
88. Hornig DH and Moser U, 1981. The safety of high vitamin C intakes in man. In: Vitamin C (ascorbic acid). Eds Counsell JN and Hornig DH. Applied Science Publishers, London, pp. 225–248.
89. Hutchinson J, Lentjes MA, Greenwood DC, Burley VJ, Cade JE, Cleghorn CL, Threapleton DE, Key TJ, Cairns BJ, Keogh RH, Dahm CC, Brunner EJ, Shipley MJ, Kuh D, Mishra G, Stephen AM, Bhaniani A, Borgulya G and Khaw KT, 2012. Vitamin C intake from diary recordings and risk of breast cancer in the UK Dietary Cohort Consortium. European Journal of Clinical Nutrition, 66, 561–568.
90. IARC (International Agency for Research on Cancer), 2012. World Health Organization. Chemical Agents and related Occupations. Volume 100F. A review of human carcinogens. Available online: http://monographs.iarc.fr/ENG/Monographs/vol100F/mono100F.pdf.
91. ICBA (International Council of Beverages Associations), 2006. Guidance Document to Mitigate the Potential for Benzene Formation in Beverages. Available online: http://www.icba-net.org/files/resources/icba-benzene-guidance-english.pdf.
92. Ishidate M Jr, Sofuni T, Yoshikawa K, Hayashi M, Nohmi M, Sawada M and Matsuoka A, 1984. Primary mutagenicity screening of food additives currently used in Japan. Food and Chemical Toxicology, 22, 623–626.
93. Ishidate M Jr, Harnois MC and Soduni T, 1988. A comparative analysis of data on the clastogenicity of 951 chemical substances tested in mammalian cell culture. Mutation Research, 195, 151–213.
94. JECFA (Joint FAO/WHO Expert Committee on Food Additives), 1962. Evaluation of the toxicity of a number of antimicrobials and antioxidants. Sixth Report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series No 228; FAO Nutrition Meetings Report Series No 31.
95. JECFA (Joint FAO/WHO Expert Committee on Food Additives), 1974a. Toxicological evaluation of certain food additieves with a review of general principles and of specifications. Seventeenth Report of the Joint FAO/WHO Expert Committee on Food Additives. WHO Technical Report Series 539. Available online: http://whqlibdoc.who.int/trs/WHO_TRS_539.pdf.
96. JECFA (Joint FAO/WHO Expert Committee on Food Additives), 1974b. Toxicological evaluation of some food additives including anticaking agents, antimicrobials, antioxidants, emulisfiers and thikening agents. Seventeenth Meeting of the Joint FAO/WHO Expert Committee on Food Additives. Food Additive Series No 5. Available online: http://www.inchem.org/documents/jecfa/jecmono/v05je20.htm.
97. JECFA (Joint FAO/WHO Expert Committee on Food Additives), 1981a. Evaluation of certain food additives. Twenty-fifth meeting of the Joint FAO/WHO Expert Committee on Food Additives. Technical Report Series No 669. Available online: http://whqlibdoc.who.int/trs/WHO_TRS_669.pdf.
98. JECFA (Joint FAO/WHO Expert Committee on Food Additives), 1981b. Toxicological evaluation of certain food additives. Twenty-fifth meeting of the Joint FAO/WHO Expert Committee on Food Additives. Food Additive Series No 16. Available online: http://www.inchem.org/documents/jecfa/jecmono/v16je06.htm.
99. JECFA (Joint FAO/WHO Expert Committee on Food Additives), 1993. JECFA Monograph. 545. Saccharin. WHO Food Additives Series 17. Available online: http://www.inchem.org/documents/jecfa/jecmono/v17je25.htm.
100. JECFA (Joint FAO/WHO Expert Committee on Food Additives), 2006. Monograph 1. Combined compendium of food additive specifications. Available online: http://www.fao.org/ag/agn/jecfa-additives/search.html.
101. Johnston CS, 1999. Biomarkers for establishing a tolerable upper intake level for vitamin C. Nutrition Reviews, 57, 71–77 (as referred to EFSA NDA Panel, 2013).
102. Kall MA and Andersen C, 1999. Improved method for simultaneous determination of ascorbic acid and dehydroascorbic acid, isoascorbic acid and dehydroisoascorbic acid in food and biological samples. Journal of Chromatography B, 730, 101–111.
103. Kallner A, Hartmann D and Hornig D, 1977. Absorption of ascorbic-acid in man. International Journal for Vitamin and Nutrition Research, 47, 383–388.
104. Kallner A, Hartmann D and Hornig D, 1979. Steady-state turnover and body pool of ascorbic-acid in man. American Journal of Clinical Nutrition, 32, 530–539.
105. Kallner A, Hornig D and Pellikka R, 1985. Formation of carbon-dioxide from ascorbate in man. American Journal of Clinical Nutrition, 41, 609–613.
106. Khan PK and Sinha SP. Antimutagenic profile of antioxidant vitamins in drosophila mulation test. Diodemidal and Environmental Sciences, 21, 163–166.
107. Kitano K, Fukukawa T, Ohtsuji Y, Masuda T and Yamaguchi H, 2002. Mutagenicity and DNA-damaging activity caused by decomposed products of potassium sorbate reacting with ascorbic acid in the presence of Fe salt. Food and Chemical Toxicology, 40, 1589–1594.
108. Koletzko B, Dokoupil K, Reitmayr S, Weinert-Harendza B and Keller E, 2000. Dietary fat intakes in infants and primary school children in Germany. The American Journal of Clinical Nutrition, 7(2(suppl.)1392S–1398S.
109. Krishna G, Nath J and Ong T, 1986. Inhibition of cyclophosphamide and mitocycin C-induced sister chromatid exchanges in mice. Cancer Research, 46, 2670–2674.
110. Lamarche JN, Nair R, Peguero A and Courville C, 2011. Vitamin C-induced oxalate nephropathy. International Journal of Nephrology, 146927, 4 pp.
111. Levine M, ConryCantilena C, Wang YH, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J and Cantilena LR, 1996. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences of the United States of America, 93, 3704–3709.
112. Levine M, Daruwala RC, Park JB, Rumsey SC and Wang Y, 1998. Does vitamin C have a pro-oxidant effect? Nature, 395, 231–232.
113. Lina BAR and Woutersen RA, 1989. Interplay of urinary sodium and potassium concentration with urinary pH in urinary bladder carcinogenesis in rats. Carcinogenesis, 10, 1733–1736.
114. Littlefield NA and Hass BS, 1995. Damage to DNA by cadmium or nickel in the presence of ascorbate. Annals of Clinical & Laboratory Science, 25, 485–492.
115. Litton Bionetics, 1975. Mutagenicity evaluation of compound FDA71-65 ascorbic acid. Report No 223-74-2104. Submitted by FDA in response to an FOI request in 1999, 46 pp. (as referred to by CIR, 2005).
116. Litton Bionetics, 1976. Mutagenicity evaluation of sodium ascorbate USP, FCC, FDA 75–64 final report. Report No 223-76-2101. Submitted by FDA in response to an FOI request in 1999. 32 pp. (as referred to by CIR, 2005).
117. Lo LW and Stich HF, 1978. The use of short-term tests to measure the preventive action of reducing agents on formation and activation of carcinogenic nitroso compounds. Mutation Research, 57, 57–67.
118. Louarme L and Billaud C, 2012. Evaluation of ascorbic acid and sugar degradation products during fruit dessert processing under conventional or ohmic heating treatment. LWT Food Science and Technology, 49, 184–187.
119. McNeal TP, Nyman PJ, Diachenko GW and Hollifield HC, 1993. Survey of benzene in foods by using headspace concentration techniques and capillary gas chromatography. Journal of AOAC International, 76, 1213–1219.
120. Macrae WD and Stich HF, 1979. Induction of sister chromatid exchanges in Chinese hamster cells by the reducing agents bisulfite and ascorbic acid. Toxicology, 13, 167–174.
121. Massey LK, Liebman M and Kynast-Gales SA, 2005. Ascorbate increases human oxaluria and kidney stone risk. Journal of Nutrition, 135, 1673–1677.
122. Miller B, Pujadas E and Gocke E, 1995. Evaluation of the micronucleus test in vivo using Chinese hamster cells. Environmental and Molecular Mutagenesis, 26, 240–247.
123. Miyagawa M, Takasawa H, Sugiyama A, Inoue Y, Murata T, Uno Y and Yoshikawa K, 1995. The in vitro-in vivo replicative DNA synthesis (RDS) test with hepatocytes prepared from male B6C3F1 mice as an early prediction assay for putative nongenotoxic (Ames-negative) mouse hepatocytes. Mutation Research, 343, 157–183.
124. Myhr BC and Caspary WJ, 1991. Chemical mutagenesis at the thymidine kinase locus in L5178Y mouse lymphoma cells: results for 31 coded compounds in the National Toxicology Program. Environmental and Molecular Mutagenesis, 18, 51–83.
125. Nagel G, Linseisen J, Van Gils CH, Peeters PH, Boutron-Ruault MC, Clavel-Chapelon F, Romieu I, Tjonneland A, Olsen A, Roswall N, Witt PM, Overvad K, Rohrmann S, Kaaks R, Drogan D, Boeing H, Trichopoulou A, Stratigakou V, Zylis D, Engeset D, Lund E, Skeie G, Berrino F, Grioni S, Mattiello A, Masala G, Tumino R, Zanetti R, Ros MM, Bueno-de-Mesquita HB, Ardanaz E, Sanchez MJ, Huerta JM, Amiano P, Rodriguez L, Manjer J, Wirfalt E, Lenner P, Hallmans G, Spencer EA, Key TJ, Bingham S, Khaw KT, Rinaldi S, Slimani N, Boffetta P, Gallo V, Norat T and Riboli E, 2010. Dietary beta-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Breast Cancer Research and Treatment, 119, 753–765.
126. Nandi BK, Majumder AK, Subraman N and Charrerj IB, 1973. Effects of large doses of vitamin-C in guinea pigs and rats. Journal of Nutrition, 103, 1688–1695.
127. Nemet I and Monnier VM, 2011. Vitamin C degradation products and pathways in the human lens. The Journal of Biological Chemistry, 286, 37128–37136.
128. Nissen SB, Tjonneland A, Stripp C, Olsen A, Christensen J, Overvad K, Dragsted LO and Thomsen B, 2003. Intake of vitamins A, C, and E from diet and supplements and breast cancer in postmenopausal women. Cancer Causes & Control, 14, 695–704.
129. Novicki DL, Rosenberg MR and Michalopoulos G, 1985. Inhibition of DNA synthesis by chemical carcinogens in cultures of initiated and normal proliferating rat hepatocytes. Cancer Research, 45, 337–344.
130. NTP (National Toxicology Program), 1983. National Toxicology Program Technical Report Series No 247: Carcinogenesis bioassay of L-ascorbic acid (vitamin C) (CAS No 50-81-7) in F344/N rats and B6C3F1 mice (feed study). Available online: http://ntp.niehs.nih.gov/ntp/htdocs/LT_rpts/tr247.pdf.
131. OECD (Organisation for Economic Co-operation and Development), 2014. OECD Guideline for the testing of chemicals. Mammalian erythrocyte micronucleus test. TG 474. Adopted 26 September 2014.
132. Omura H, Shinohara K, Maeda H, Noaka M and Murakami H, 1978. Mutagenic action of triose reductone and ascorbic acid on Salmonella typhimurium TA 100 strain. Journal of Nutritional Science and Vitaminology, 24, 185–194.
133. Oster B and Fechtel U, 2012. Vitamins, 7. Vitamin C (L-Ascorbic Acid). Ullmann's Encyclopedia of Industrial Chemistry. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany.
134. Pachla LA, Reynolds DL and Kissinger PT, 1985. Analytical methods for determining ascorbic-acid in biological samples, food-products, and pharmaceuticals. Journal of the Association of Official Analytical Chemists, 68, 1–12.
135. Phillips BJ, Jackson LI, Tate B, Price RJ, Adams TB, Ford RA, Goodinan JI and Lake BJ, 1997. Furfural does not induce unscheduled DNA synthesis (UDS) in the in vivo rat hepatocyte DNA repair assay. Presented 1997 Society of Toxicology Annual Meeting, Cincinnati, Ohio (as referred to by EFSA CEF Panel, 2011).
136. Pienkowsha K, Gajcy H and Koziorowska J, 1985. Protective effect of ascorbic acid against mutagenicity of aminopyrine plus nitrite. Polish Journal of Pharmacology and Pharmacy, 37, 601–607.
137. Prieme H, Loft S, Nyyssonen K, Salonen JT and Poulsen HE, 1997. No effect of supplementation with vitamin E, ascorbic acid, or coenzyme Q10 on oxidative DNA damage estimated by 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion in smokers. American Journal of Clinical Nutrition, 65, 503–507.
138. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P and Lunec J, 1998. Vitamin C exhibits pro-oxidant properties. Nature, 392, 559–559.
139. Poulsen HE, Weimann A, Salonen JT, Nyyssönen K, Loft S, Cadet J, Douki T and Ravanat JL, 1998. Does vitamin C have a pro-oxidant effect? Nature, 395, 231–232.
140. Reichstein T and Grussner A, 1934. A productive synthesis of L-arcorbic acid (C-vitamin). Helvetica Chimica Acta, 17, 311–328.
141. Robichová S, Slamenová D, Chalupa I and L$ivia Šebová L, 2004. DNA lesions and cytogenetic changes induced by N-nitrosomorpholine in HepG2, V79 and VH10 cells: the protective effects of Vitamins A, C and E. Mutation Research, 560, 91–99.
142. Rosin MP, San RHC and Stich HF. 1980. Mutagenic activity of ascorbate in mammalian cell cultures. Cancer Letters, 8, 299–305.
143. Russell LF, 2013. Water soluble vitamins. In: Food analysis by HPLC. 3rd Edition. Eds Nolet LMI and Toldrà F. CRC Press Taylor and Francis Group, 331.
144. SCF (Scientific Committee on Food), 1983. Essential requirements of infant formulae and follow-up milks based on cows' milk proteins (opinion expressed 27 April 1983). Reports of the Scientific Committee for Food (fourteenth series), pp. 9–31. Available online: http://ec.europa.eu/food/fs/sc/scf/reports/scf_reports_14.pdf.
145. SCF (Scientific Committee on Food), 1989a. The minimum requirements for soya-based infant formulae and follow-up milks (opinion delivered on 9 December 1988). Reports of the Scientific Committee for Food (twenty-third series). Available online: http://ec.europa.eu/food/fs/sc/scf/reports/scf_reports_23.pdf.
146. SCF (Scientific Committee on Food), 1989b. Report on antioxidants (opinion expressed 11 December 1987). Reports of the Scientific Committee for Food (twenty-second series). Available online: http://ec.europa.eu/food/fs/sc/scf/reports/scf_reports_22.pdf.
147. SCF (Scientific Committee on Food), 1991. First report of the Scientific Committee for Food on the essential requirements for weaning foods (opinion expressed on 27 October 1989 and on 30 March 1990). Reports of the Scientific Committee for Food (twenty-fourth Series). Available online: http://ec.europa.eu/food/fs/sc/scf/reports/scf_reports_24.pdf.
148. SCF (Scientific Committee on Food), 1993. Nutrient and energy intakes for the European Community. Reports of the Scientific Committee for Food, 31st Series. Food–Science and Technique. European Commission, Luxembourg, 248 pp. Available online: http://ec.europa.eu/food/fs/sc/scf/reports/scf_reports_31.pdf.
149. SCF (Scientific Committee on Food), 1994. Opinion on certain additives for use in infant formulae, follow-on formulae and weaning food (expressed on 11 December 1992). Reports of the Scientific Committee for Food (thirty-second series). Available online: http://ec.europa.eu/food/fs/sc/scf/reports/scf_reports_32.pdf.
150. SCF (Scientific Committee on Food), 1997a. Additives in nutrient preparations for use in infant formulae, follow-on formulae and weaning foods (opinion expressed on 7 June 1996). Reports of the Scientific Committee for Food (fortieth series). Available online: http://ec.europa.eu/food/fs/sc/scf/reports/scf_reports_40.pdf.
151. SCF (Scientific Committee on Food), 1997b. Opinion on saccharin and its sodium, potassium and calcium salts (expressed on 2 June 1995). CS/ADD/EDUL/148-FINAL, February 1997. Available online: http://ec.europa.eu/food/fs/sc/oldcomm7/out26_en.pdf.
152. SCF (Scientific Committee on Food), 1998. Certain additives for use in foods for infants and young children in good health and in foods for special medical purposes for infants and young children (opinion expressed on 13 June 1997). Reports of the Scientific Committee for Food (forty-third series). Available online: http://ec.europa.eu/food/fs/sc/scf/reports/scf_reports_43.pdf.
153. SCF (Scientific Committee on Food), 2003. Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Calcium (expressed on 4 April 2003). SCF/CS/NUT/UPPLEV/64 Final 23 April 2003. Available online: http://ec.europa.eu/food/fs/sc/scf/out194_en.pdf.
154. Sharma S, Naravaneni R, Bhaumick D and Mehta RD, 2011. Effect of four antioxidant on DNA damage measurement by the Comet assay. Environmental Mutagen Society 42 Annual meeting, Abstract.
155. Shelby MD, Erexon GL, Hook GJ and Tice RR, 1993. Evaluation of a three-exposure mouse bone marrow micronucleus protocol: results with 49 chemicals. Environmental and Molecular Mutagenesis, 21, 160–179.
156. Shin DB and Feather MS, 1990. The degradation of L-ascorbic acid in neutral solutions containing oxygen. Journal of Carbohydrate Chemistry, 9, 461–469.
157. Simán CM and Eriksson UJ, 1997. Vitamin C supplementation of the maternal diet reduces the rate of malformation in the offspring of diabetic rats. Diabetologia, 40, 1416–1424.
158. Simon JA and Hudes ES, 1999. Relation of serum ascorbic acid to serum vitamin B-12, serum ferritin, and kidney stones in US adults. Archives of Internal Medicine, 159, 619–624.
159. Simpson GLW and Ortwerth BJ, 2000. The non-oxidative degradation of ascorbic acid at physiological conditions. Biochimica et Biophysica Acta, 1501, 12–24.
160. Singh PP, Kiran R, Pendse AK, Ghosh R and Surana SS, 1993. Ascorbic-acid is an abettor in calcium urolithiasis - an experimental-study. Scanning Microscopy, 7, 1041–1048.
161. Slupski J, 2011. Effect of freezing and canning on the content of vitamin C in immature seeds of five cultivars of common bean (Phaseolus vulgaris, L.), Technologia Alimentaria, Acta Scientiarum Polonorum, 10, 199–208.
162. Stadtman ER, 1991. Ascorbic acid and oxidative inactivation of proteins. American Journal of Clinical Nutrition, 54, 1125S–1128S.
163. Speit G, Wolf M and Vogel W, 1980. The SCE-inducing capacity of vitamin C: investigations in vitro and in vivo. Mutation Research, 78, 273–278.
164. Stein HB, Hasan A and Fox IH, 1976. Ascorbic acid-induced uricosuria–consequence of megavitamin therapy. Annals of Internal Medicine, 84, 385–388.
165. Steinbrenner N, Löbell-Behrends S, Reusch H, Kuballa T and Lachenmeier DW, 2010. Benzol in Lebensmitteln – Ein Überblick. Journal für Verbraucherschutz und Lebensmittelsicherheit [Journal of Consumer Protection and Food Safety], 5, 443–452.
166. Stich HF, Karim J, Koropatnick J and Lo L, 1976. Mutagenic action of ascorbic acid. Nature, 260, 722–724.
167. Stich HG, Wei L and Whitting RF, 1980. Chromosome aberrations in mammalian cells exposed to vitamin C and multiple vitamin pills. Food and Cosmetics Toxicology, 18, 497–501.
168. Steskova A, Morochovicova M and Leskova E, 2006. Vitamin C degradation during storage of fortified foods. Journal of Food and Nutrition Research, 45, 55–61.
169. Surber W and Cerioli A, 1971. Final report on a two-year toxicity study with L-ascorbic acid on rats. Unpublished study performed at Battelle Laboratories, Geneva for Hoffmann–La Roche AG.
170. Takahashi O, 1995. Hemorrhagic toxicity of a large dose of alpha-tocopherol, beta-tocopherol, gamma-tocopherol and delta-tocopherol, ubiquinone, beta-carotene, retinol acetate and l-ascorbic-acid in the rat. Food and Chemical Toxicology, 33, 121–128.
171. Taylor JM and Friedman L, 1974. Combined chronic feeding and three-generation reproduction study of sodium saccharin in the rat. Toxicology and Applied Pharmacology, 29, 154 (abstract No 200) (as referred to by JECFA, 1993).
172. Taylor EN, Stampfer MJ and Curhan GC, 2004. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. Journal of the American Society of Nephrology, 15, 3225–3232.
173. TemaNord, 2002. Food additives in Europe 2000 – status of safety assessments of food additives presently permitted in the EU: Nordic Council of Ministers, TemaNord 2002:560. Available online: http://www.norden.org/sv/publikationer/publikationer/2002–2560.
174. Tennant D, 2004. Usage of tocopherols and ascorbates in food and non-alcoholic beverages. Assessment provided for DSM Nutritional products, BASF and DuPont Nutrition Biosciences. 9 January, 104. Unpublished study report.
175. Thewlis BH, 1971. Fate of ascorbic acid in Chorleywood bread process. Journal of the Science of Food and Agriculture, 22, 16–19.
176. Tisdel MO et al., 1974. Long-term feeding of saccharin in rats. In: Sweetness, symposium. Ed. Inglett GE. AVI Publishing Co., Westport, Connecticut, 145 pp. (as referred to by JECFA, 1993).
177. Tripathy NK, Wurgler FE and Frei H, 1990. Genetic toxicity of 6 carcinogens and 6 noncarcinogens in the drosophila wing spot-test. Mutation Research, 242, 169–180.
178. Uchida K and Kawakishi S, 1988. Selective oxidation of tryptophan and histidine residues in protein through the copper-catalyzed autoxidation of L-ascorbic acid. Agricultural and Biological Chemistry, 52, 1529–1535.
179. Uchida K, Enomoto N, Itakura K and Kawakishi S, 1989. The hydroxyl radical generated by an iron(II)/EDTA/ascorbate system preferentially attacks tryptophan residues of the protein. Agricultural and Biological Chemistry, 53, 3285–3292.
180. Visakh PM, Iturriaga LB and Ribotta PD, 2014. Effect of heat processing. In: Advances in food science and nutrition. Volume 2. Ed. Scrivener Publishing, Wiley, NJ, USA.
181. Wang S, Berge GE, Hoem NO and Sund RB, 2001. Pharmacokinetics in dogs after oral administration of two different forms of ascorbic acid. Research in Veterinary Science, 71, 27–32.
182. WCRF/AICR (World Cancer Research Fund/American Institute for Cancer Research), 2007. Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective. 537 pp.
183. Weitberg AB, 1987. Antioxidants inhibit the effect of vitamin C on oxygen radical-induced sister chromatid exchange. Mutation Research, 191, 53–56.
184. Weitzman SA and Stossel TP, 1982. Effects of oxygen radical scavengers and antioxidants on phagocyte-induced mutagenesis. Journal of Immunology, 128, 2770–2772.
185. WHO (World Health Organization), 2009a. Infant and young child feeding: model chapter for textbooks for medical students and allied health professionals. Geneva, World Health Organization. Available online: http://apps.who.int/iris/bitstream/10665/44117/1/9789241597494_eng.pdf?ua=1.
186. WHO (World Health Organization), 2009b. Principles and Methods for the Risk Assessment of Chemicals in Food, International Programme on Chemical Safety, Environmental Health Criteria 240. Chapter 2: Risk Assessment and its Role in Risk Analysis. Available online: http://whqlibdoc.who.int/ehc/WHO_EHC_240_5_eng_Chapter2.pdf.
187. WHO (World Health Organization), 2011. Guidelines for Drinking-water Quality. Fourth Edition. Benzene, p. 322. Available online: http://www.who.int/water_sanitation_health/dwq/guidelines/en/.
188. Wollenberg P and Rummel W, 1987. Dependence of intestinal iron absorption on the valency state of iron. Naunyn-Schmiedeberg's Archives of Pharmacology, 336, 578–582 (as referred to by EFSA NDA Panel, 2013).
189. Zeiger E, Anderson B, Haworth S, Lawlor T and Mortelmans K, 1988. Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environmental and Molecular Mutagenesis, 11 (Suppl. 12), 1–157.